Calidris Bio
0719.970.820 · rovalta.com · 07/11/2026
Calidris Bio
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOCalidris Bio is a Private limited company incorporated in 2019. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Antwerpen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0719.970.820
- Incorporation
- 07/02/2019
- Legal form
- Private limited company
- Registered office
- Olieweg 95
2020 Antwerpen · FlandreSee on map - Contributed capital
- 230 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 7 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -69,3 k € | -143% | 161,6 k € | +546% | 25 k € | +343% | 5,6 k € | +147% | -12,1 k € |
| EBITDA | -237 k € | -3211% | -7,2 k € | +83.3% | -42,8 k € | -57.7% | -27,1 k € | +17.5% | -32,9 k € |
| Operating result | -295,3 k € | -351% | -65,5 k € | +27.2% | -90 k € | -37.2% | -65,6 k € | -7.3% | -61,1 k € |
| Net result | -256,5 k € | -1354% | -17,6 k € | +57.1% | -41,1 k € | -9.0% | -37,7 k € | +6.9% | -40,5 k € |
| Balance sheet | |||||||||
| Equity | -114,5 k € | -337% | -26,2 k € | -159% | 44,1 k € | -55.4% | 98,9 k € | -41.5% | 169 k € |
| Total assets | 506,8 k € | +3.4% | 490,1 k € | -18.9% | 604,2 k € | -19.2% | 747,6 k € | +147% | 302,5 k € |
| Cash | 129,9 k € | +51.9% | 85,5 k € | +3742% | 2,2 k € | -98.8% | 191 k € | +715% | 23,4 k € |
| Debts | 601,2 k € | +29.8% | 463,1 k € | +82.5% | 253,8 k € | +85.5% | 136,9 k € | +2.5% | 133,5 k € |
Board of directors
Source · NBB, accounts to 31/12/20253 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 24/10/2022 | |||
Johan Gheeraert | Directorsince 06/02/2019 | ||
Lieve Hoflack | Directorsince 06/02/2019 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Brecht Vanlerberghe | Director06/02/2019 → 2021 accounts | ||
Frederik De Bruyn | Director07/02/2019 → 2021 accounts | ||
Frederik Debruyn | Director06/02/2019 → 2019 accounts |
Other companies at this address
Olieweg 95 2020 Antwerpen| Company | CBE no. |
|---|---|
ALLEGRO● Active | 0766.984.740 |
Aquature Technologies● Active | 0797.486.488 |
Atomic 16● Active | 0802.125.068 |
Bloom Biotech● Active | 1019.958.463 |
BlueChem● Active | 0673.921.455 |
Carboganic● Active | 0760.530.280 |
Catalisti● Active | 0842.026.316 |
Creaflow● Active | 0696.864.727 |
D-CRBN● Active | 0765.921.601 |
FLYBLAST● Bankrupt | 1001.037.129 |
Goal7● Active | 1040.911.750 |
| 0767.629.591 | |
Metallon Clean Extractions● Active | 0793.397.840 |
MICRO ARC● Active | 0794.955.580 |
Optanic● Active | 0792.548.002 |
Peace of Meat● Bankrupt | 0731.861.238 |
QUANTEM INNOVATIONS● Active | 1044.062.963 |
Solvakem Belgium● Active | 0743.650.203 |
Steakholder Foods Europe● Liquidation | 0762.872.435 |
Tales of land● Active | 0802.124.969 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 19/06/2026 | 16/07/2025 | 23/07/2024 | 23/06/2023 | 27/07/2022 | 28/07/2021 |
| General meeting | 08/06/2026 | 10/06/2025 | 10/06/2024 | 12/06/2023 | 13/06/2022 | 14/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 08/06/2026 | 19/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 10/06/2025 | 16/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 10/06/2024 | 23/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 12/06/2023 | 23/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 13/06/2022 | 27/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 14/06/2021 | 28/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 08/06/2020 | 01/07/2020 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 24/10/2022 | |||
Johan Gheeraert | Directorsince 06/02/2019 | ||
Lieve Hoflack | Directorsince 06/02/2019 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Brecht Vanlerberghe | Director06/02/2019 → 2021 accounts | ||
Frederik De Bruyn | Director07/02/2019 → 2021 accounts | ||
Frederik Debruyn | Director06/02/2019 → 2019 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other23/01/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN
- Mandates26/08/2024ONTSLAGEN - BENOEMINGEN
- Mandates06/06/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
- Mandates02/02/2023ONTSLAGEN - BENOEMINGEN
- Mandates09/08/2022ONTSLAGEN - BENOEMINGEN
- Registered office24/11/2020MAATSCHAPPELIJKE ZETEL - WIJZIGING RECHTSVORM
- Other11/02/2019RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Olieweg 95, 2020 Antwerp-2020Current | CBE | |
| Olieweg 95, 2000 Antwerp | accounts 2022 → 2025 | Accounts 2025 · 2026-00185093 |
| Olieweg 95, 2020 Antwerp-2020 | accounts 2021 | Accounts 2021 · 2022-20263872 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Calidris BioCurrent | accounts 2019 → 2025 | Accounts 2025 · 2026-00185093 |
Events
- 2025Annual accounts 2025-256,5 k €↓
- 2024Annual accounts 2024-17,6 k €↑
- 2023Annual accounts 2023-41,1 k €↓
- 2022Annual accounts 2022-37,7 k €↑
- 2021Annual accounts 2021-40,5 k €↓
- 2019Annual accounts 201923,9 k €
- 07/02/2019IncorporationPrivate limited company